Neurofibromatosis 1 is one of the most common genetic conditions affecting the nervous system. Individuals with NF1 are predisposed to the development of peripheral nerve sheath tumors (neurofibromas and MPNSTs), astrocytomas (optic pathway gliomas), learning disabilities, seizures, strokes, macrocephaly, and vascular abnormalities. The NF1 tumor suppressor gene encodes a large protein (neurofibromin) that functions primarily as a RAS negative regulator, suggesting that targeted therapy for NF1 might derive from inhibition of the RAS signaling pathway.

Original languageEnglish
Pages (from-to)841-865
Number of pages25
JournalNeurologic Clinics
Issue number3
StatePublished - Aug 2002


Dive into the research topics of 'Neurofibromatosis 1'. Together they form a unique fingerprint.

Cite this